About Dognostica
Dognostica is a company based in London (United Kingdom) founded in 2017 by Golan Nir and Tamir Goren. Dognostica operates in a competitive market with competitors including Kozhnosys and SpiraCheck, among others.
- Headquarter London, United Kingdom
- Founders Golan Nir, Tamir Goren
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Dognostica Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Aktiv
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Dognostica
Investors in Dognostica
Dognostica has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Aktiv and MassChallenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked | |
|
A platform for job listings targeting women in Shibuya is operated.
|
Locked | Locked | Locked |
Investor details for Dognostica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dognostica
Investment portfolio details for Dognostica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dognostica
Detailed financials for Dognostica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dognostica Comparisons
Peer comparison for Dognostica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dognostica
Dognostica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kozhnosys and SpiraCheck, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of breath analyzers to detect diseases
|
|
| Locked | Locked | Locked |
Develops breath tests for early detection of multiple cancers to improve survival.
|
Detailed competitors of Dognostica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dognostica
Complete news archive for Dognostica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dognostica
Dognostica was founded in 2017.
Dognostica is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Dognostica provides canine-assisted cancer screening. The company will diagnose for cancers like prostate, colorectal, bladder, ovarian, as well as Parkinsons. The test needs an individual to breathe into a tube which will then be sealed and sent to the laboratory for testing. The smell of the breath will be detected by the dogs for the detection of cancer.
Dognostica's top competitors include Kozhnosys and SpiraCheck.
Dognostica has 2 investors. Key investors include Aktiv, and MassChallenge.